474 related articles for article (PubMed ID: 23151166)
1. Chikungunya virus and prospects for a vaccine.
Weaver SC; Osorio JE; Livengood JA; Chen R; Stinchcomb DT
Expert Rev Vaccines; 2012 Sep; 11(9):1087-101. PubMed ID: 23151166
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.
Chu H; Das SC; Fuchs JF; Suresh M; Weaver SC; Stinchcomb DT; Partidos CD; Osorio JE
Vaccine; 2013 Jul; 31(33):3353-60. PubMed ID: 23727003
[TBL] [Abstract][Full Text] [Related]
3. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P
J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.
Muthumani K; Lankaraman KM; Laddy DJ; Sundaram SG; Chung CW; Sako E; Wu L; Khan A; Sardesai N; Kim JJ; Vijayachari P; Weiner DB
Vaccine; 2008 Sep; 26(40):5128-34. PubMed ID: 18471943
[TBL] [Abstract][Full Text] [Related]
5. Development of Vaccines for Chikungunya Fever.
Erasmus JH; Rossi SL; Weaver SC
J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
[TBL] [Abstract][Full Text] [Related]
6. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
7. Chikungunya: a potentially emerging epidemic?
Thiboutot MM; Kannan S; Kawalekar OU; Shedlock DJ; Khan AS; Sarangan G; Srikanth P; Weiner DB; Muthumani K
PLoS Negl Trop Dis; 2010 Apr; 4(4):e623. PubMed ID: 20436958
[TBL] [Abstract][Full Text] [Related]
8. Approaches to the treatment of disease induced by chikungunya virus.
Bettadapura J; Herrero LJ; Taylor A; Mahalingam S
Indian J Med Res; 2013 Nov; 138(5):762-5. PubMed ID: 24434329
[TBL] [Abstract][Full Text] [Related]
9. Chimeric alphavirus vaccine candidates for chikungunya.
Wang E; Volkova E; Adams AP; Forrester N; Xiao SY; Frolov I; Weaver SC
Vaccine; 2008 Sep; 26(39):5030-9. PubMed ID: 18692107
[TBL] [Abstract][Full Text] [Related]
10. A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.
Chattopadhyay A; Wang E; Seymour R; Weaver SC; Rose JK
J Virol; 2013 Jan; 87(1):395-402. PubMed ID: 23077320
[TBL] [Abstract][Full Text] [Related]
11. Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus.
Darwin JR; Kenney JL; Weaver SC
Am J Trop Med Hyg; 2011 Jun; 84(6):1012-5. PubMed ID: 21633043
[TBL] [Abstract][Full Text] [Related]
12. Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism.
Plante K; Wang E; Partidos CD; Weger J; Gorchakov R; Tsetsarkin K; Borland EM; Powers AM; Seymour R; Stinchcomb DT; Osorio JE; Frolov I; Weaver SC
PLoS Pathog; 2011 Jul; 7(7):e1002142. PubMed ID: 21829348
[TBL] [Abstract][Full Text] [Related]
13. Chikungunya: a re-emerging virus.
Burt FJ; Rolph MS; Rulli NE; Mahalingam S; Heise MT
Lancet; 2012 Feb; 379(9816):662-71. PubMed ID: 22100854
[TBL] [Abstract][Full Text] [Related]
14. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.
Salazar-González JA; Angulo C; Rosales-Mendoza S
Vaccine; 2015 Jul; 33(31):3650-8. PubMed ID: 26073010
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.
Roy CJ; Adams AP; Wang E; Plante K; Gorchakov R; Seymour RL; Vinet-Oliphant H; Weaver SC
J Infect Dis; 2014 Jun; 209(12):1891-9. PubMed ID: 24403555
[TBL] [Abstract][Full Text] [Related]
17. Chikungunya in Southeast Asia: understanding the emergence and finding solutions.
Pulmanausahakul R; Roytrakul S; Auewarakul P; Smith DR
Int J Infect Dis; 2011 Oct; 15(10):e671-6. PubMed ID: 21775183
[TBL] [Abstract][Full Text] [Related]
18. Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.
Bao H; Ramanathan AA; Kawalakar O; Sundaram SG; Tingey C; Bian CB; Muruganandam N; Vijayachari P; Sardesai NY; Weiner DB; Ugen KE; Muthumani K
Viral Immunol; 2013 Feb; 26(1):75-83. PubMed ID: 23409931
[TBL] [Abstract][Full Text] [Related]
19. Serological correlates of immune protection conferred by Chikungunya virus infection.
Sheela PJ; Sumathy K
Acta Virol; 2013; 57(4):471-3. PubMed ID: 24294963
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P
J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]